ATE288494T1 - Toleranzinduktion mit tolerogenischen fusionsproteinen - Google Patents
Toleranzinduktion mit tolerogenischen fusionsproteinenInfo
- Publication number
- ATE288494T1 ATE288494T1 AT95910220T AT95910220T ATE288494T1 AT E288494 T1 ATE288494 T1 AT E288494T1 AT 95910220 T AT95910220 T AT 95910220T AT 95910220 T AT95910220 T AT 95910220T AT E288494 T1 ATE288494 T1 AT E288494T1
- Authority
- AT
- Austria
- Prior art keywords
- epitopes
- tolerogenic
- immunoglobulin
- inducing
- provides methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Transplantation (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fuses (AREA)
- Burglar Alarm Systems (AREA)
- Control Of High-Frequency Heating Circuits (AREA)
- Lining Or Joining Of Plastics Or The Like (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/195,874 US5817308A (en) | 1994-02-14 | 1994-02-14 | Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance |
PCT/US1995/001671 WO1995021926A1 (en) | 1994-02-14 | 1995-02-10 | Inducing tolerance with tolerogenic fusion proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE288494T1 true ATE288494T1 (de) | 2005-02-15 |
Family
ID=22723177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95910220T ATE288494T1 (de) | 1994-02-14 | 1995-02-10 | Toleranzinduktion mit tolerogenischen fusionsproteinen |
Country Status (10)
Country | Link |
---|---|
US (2) | US5817308A (de) |
EP (1) | EP0741788B1 (de) |
JP (2) | JPH09509316A (de) |
AT (1) | ATE288494T1 (de) |
CA (1) | CA2182977A1 (de) |
DE (1) | DE69533979T8 (de) |
DK (1) | DK0741788T3 (de) |
ES (1) | ES2233940T3 (de) |
PT (1) | PT741788E (de) |
WO (1) | WO1995021926A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5817308A (en) * | 1994-02-14 | 1998-10-06 | University Of Rochester | Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance |
US6485726B1 (en) * | 1995-01-17 | 2002-11-26 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
US5843462A (en) * | 1995-11-30 | 1998-12-01 | Regents Of The University Of Minnesota | Diphtheria toxin epitopes |
CA2315537A1 (en) | 1997-12-16 | 1999-06-24 | Regents Of The University Of Minnesota | Methods to treat undesirable immune responses |
KR100518958B1 (ko) * | 1998-05-20 | 2005-10-06 | 추가이 세이야쿠 가부시키가이샤 | 신규한 유전자 클로닝 방법 |
US6884785B2 (en) * | 1999-06-17 | 2005-04-26 | The Scripps Research Institute | Compositions and methods for the treatment or prevention of autoimmune diabetes |
WO2001080880A2 (de) * | 2000-04-22 | 2001-11-01 | Stefan Barth | Apoptotika |
IL154284A0 (en) * | 2000-09-25 | 2003-09-17 | Nestle Sa | Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
US8703146B2 (en) * | 2001-04-20 | 2014-04-22 | Institute For Systems Biology | Toll-like receptor 5 ligands and methods of use |
WO2002085933A1 (en) * | 2001-04-20 | 2002-10-31 | The Institute For Systems Biology | Toll-like receptor 5 ligands and methods of use |
US7265208B2 (en) * | 2001-05-01 | 2007-09-04 | The Regents Of The University Of California | Fusion molecules and treatment of IgE-mediated allergic diseases |
US20120148585A1 (en) * | 2001-05-01 | 2012-06-14 | Andrew Saxon | Fusion molecules and methods for treatment of immune diseases |
US7744876B2 (en) | 2002-04-09 | 2010-06-29 | The Curators Of The University Of Missouri | Methods and compositions for treatment, prevention, suppression, and/or delaying the onset of type 1 diabetes |
US8603472B2 (en) * | 2002-04-09 | 2013-12-10 | The Curators Of The University Of Missouri | Methods and compositions reversing pre-diabetes using fusion proteins comprising a GAD peptide |
US8609091B2 (en) | 2002-04-09 | 2013-12-17 | The Curators Of The University Of Missouri | Method for endocytic presentation of an immunosuppressive for the treatment of type 1 diabetes |
US8603471B2 (en) * | 2002-04-09 | 2013-12-10 | The Curators Of The University Of Missouri | Methods and compositions for preventing the onset of type 1 diabetes |
US8029803B2 (en) | 2002-06-20 | 2011-10-04 | Paladin Labs, Inc. | Chimeric antigens for eliciting an immune response |
US8025873B2 (en) | 2002-06-20 | 2011-09-27 | Paladin Labs, Inc. | Chimeric antigens for eliciting an immune response |
US8007805B2 (en) * | 2003-08-08 | 2011-08-30 | Paladin Labs, Inc. | Chimeric antigens for breaking host tolerance to foreign antigens |
CN101300355A (zh) * | 2005-10-13 | 2008-11-05 | 威瑞克斯医药公司 | 包含丙型肝炎病毒多肽和用于引起免疫应答的Fc片段的嵌合抗原 |
EP2423222B2 (de) * | 2007-01-30 | 2020-07-29 | Epivax, Inc. | Regulatorische T-Zellen-Epitopen sowie Zusammensetzungen damit und Anwendungen davon |
CN102405057B (zh) | 2009-03-23 | 2016-05-25 | 那尼尔科斯治疗公司 | 用免疫刺激性Hiv Tat衍生物多肽治疗癌症 |
KR20150010716A (ko) | 2012-03-23 | 2015-01-28 | 더 유니버시티 오브 퀸스랜드 | 면역조절제 및 이의 용도 |
CA2926221A1 (en) | 2013-10-04 | 2015-04-09 | Pin Pharma, Inc. | Immunostimulatory hiv tat derivative polypeptides for use in cancer treatment |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2047244C (en) * | 1989-02-24 | 2002-09-17 | Zanetti Maurizio | Genetically engineered immunoglobulins |
US6248332B1 (en) * | 1990-10-05 | 2001-06-19 | Medarex, Inc. | Targeted immunostimulation with bispecific reagents |
GB9021679D0 (en) * | 1990-10-05 | 1990-11-21 | Gorman Scott David | Antibody preparation |
US5167956A (en) * | 1991-02-11 | 1992-12-01 | The United States Of America As Represented By The Department Of Health And Human Services | Immunotoxin with in-vivo t cell suppressant activity |
US5817308A (en) * | 1994-02-14 | 1998-10-06 | University Of Rochester | Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance |
-
1994
- 1994-02-14 US US08/195,874 patent/US5817308A/en not_active Expired - Lifetime
-
1995
- 1995-02-10 CA CA002182977A patent/CA2182977A1/en not_active Abandoned
- 1995-02-10 DE DE69533979T patent/DE69533979T8/de not_active Expired - Fee Related
- 1995-02-10 ES ES95910220T patent/ES2233940T3/es not_active Expired - Lifetime
- 1995-02-10 PT PT95910220T patent/PT741788E/pt unknown
- 1995-02-10 JP JP7521334A patent/JPH09509316A/ja not_active Withdrawn
- 1995-02-10 WO PCT/US1995/001671 patent/WO1995021926A1/en active IP Right Grant
- 1995-02-10 AT AT95910220T patent/ATE288494T1/de not_active IP Right Cessation
- 1995-02-10 EP EP95910220A patent/EP0741788B1/de not_active Expired - Lifetime
- 1995-02-10 DK DK95910220T patent/DK0741788T3/da active
-
1998
- 1998-09-24 US US09/160,076 patent/US6838281B2/en not_active Expired - Fee Related
-
2007
- 2007-07-18 JP JP2007187377A patent/JP4214173B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0741788A1 (de) | 1996-11-13 |
DK0741788T3 (da) | 2005-05-30 |
DE69533979T8 (de) | 2006-11-09 |
PT741788E (pt) | 2005-05-31 |
JP2008001709A (ja) | 2008-01-10 |
CA2182977A1 (en) | 1995-08-17 |
ES2233940T3 (es) | 2005-06-16 |
DE69533979T2 (de) | 2006-04-27 |
US20020048562A1 (en) | 2002-04-25 |
JPH09509316A (ja) | 1997-09-22 |
EP0741788B1 (de) | 2005-02-02 |
US6838281B2 (en) | 2005-01-04 |
DE69533979D1 (de) | 2005-03-10 |
US5817308A (en) | 1998-10-06 |
JP4214173B2 (ja) | 2009-01-28 |
WO1995021926A1 (en) | 1995-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69533979D1 (de) | Toleranzinduktion mit tolerogenischen Fusionsproteinen | |
PT700445E (pt) | Proteinas de stress e suas utilizacoes | |
Sell | Studies on rabbit lymphocytes in vitro: VI. The induction of blast transformation with sheep antisera to rabbit IgA and IgM | |
ATE353362T1 (de) | Neuartige ctla4/cd28 liganden und deren anwendungen | |
EP0460076A4 (en) | Genetically engineered immunoglobulins | |
ZA924271B (en) | Tri-and tetravalent mono specific antigen binding proteins | |
SE9201331D0 (sv) | Protein l och hybridproteiner daerav | |
EP0699755A3 (de) | Verfahren zur Herstellung modifizierter Immunoglobulinen mit reduzierter Immunogenität der variablen Domänen einer murinen Antikörpers, Zusammensetzungen die diese enthalten | |
EP0245078A3 (en) | Enhancement of antigen immunogenicity | |
ATE280227T1 (de) | Epitope von stress proteinen | |
US5043429B1 (en) | Protein fragments containing factor VIII binding domain of von willebrand factor | |
ATE250133T1 (de) | Verktorvermittelte genominsertion und expression von dna in bcg | |
DE69328726D1 (de) | Verwendung synthetischer peptide zur induktion der toleranz gegen t- und b-zell epitope von autoantigenen | |
Cooper et al. | Isolation of a murine leukemia Fc receptor by selective release induced by surface redistribution | |
EP0550020A3 (en) | Anti-human ige monoclonal antibodies | |
Pedersen et al. | Antigenic Analysis of Treponema pallidum: Cross‐reactions between Individual Antigens of T. pallidum and T. Reiter | |
SG95574A1 (en) | Immunoreactive antigens of hepatitia e virus | |
DK0625157T3 (da) | Blodplade-GPIIIaP1A1- og -P1A2-epitoper og fremstilling og anvendelse deraf | |
Itoh et al. | Synthesis and secretion of alpha 1-microglobulin by human lymphocytes. | |
Ikeda et al. | Evidence for polymorphism of MB3 antigens among three HLA-D clusters associated with HLA-DR4 | |
WO1999042478A3 (en) | LEPTOSPIRAL OUTER MEMBRANE PROTEIN, LipL32 | |
ATE201046T1 (de) | Polypeptide und dafür kodierende dns, die mit humanen malariaparasiten assoziiert sind | |
BRANDTZAEG | Immunological Removal of Contaminants: a Useful Principle in Protein Purification Applied to Human Secretory Component and J Chain | |
Patel | Purification and characterization of Bovine CD36 from heart microsomes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0741788 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |